CVALF and COV Related Headlines
Go Back- Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting
- Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings
- Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%
- Covalon Reports Fiscal 2026 Third Quarter Results
- Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results
- Covalon appoints Dr. Murray Miller to board, grants DSUs
- Covalon Announces Appointment of New Director and DSU Grants
- Covalon Reports 2026 Second Quarter Results
- Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results
- Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
- Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
- Covalon Announces Grant of Deferred Share Units
- Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders
- Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026
- Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights
- Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
- Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results
- Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth
- Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results
- Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength
- Covalon Declares First Ever Special Cash Dividend
CVALF and COV Related Press Releases
Go Back- Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting
- Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings
- Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%
- Covalon Reports Fiscal 2026 Third Quarter Results
- Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results
- Covalon Announces Appointment of New Director and DSU Grants
- Covalon Reports 2026 Second Quarter Results
- Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results
- Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
- Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
- Covalon Announces Grant of Deferred Share Units
- Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders
- Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026
- Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights
- Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
- Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results
- Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth
- Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results
- Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength
- Covalon Declares First Ever Special Cash Dividend
